PAA
Peregrine Asset Advisers’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.18M | Buy |
2,796
+1
| +0% | +$779 | 0.68% | 40 |
|
|
2025
Q1 | $2.31M | Sell |
2,795
-32
| -1% | -$26.4K | 0.86% | 37 |
|
|
2024
Q4 | $2.18M | Sell |
2,827
-2,910
| -51% | -$2.25M | 0.8% | 38 |
|
|
2024
Q3 | $5.08M | Sell |
5,737
-1,859
| -24% | -$1.65M | 1.75% | 16 |
|
|
2024
Q2 | $6.88M | Sell |
7,596
-2,030
| -21% | -$1.84M | 2.71% | 5 |
|
|
2024
Q1 | $7.49M | Buy |
9,626
+1,519
| +19% | +$1.18M | 2.99% | 7 |
|
|
2023
Q4 | $4.73M | Sell |
8,107
-2,797
| -26% | -$1.63M | 2.29% | 10 |
|
|
2023
Q3 | $5.86M | Buy |
+10,904
| New | +$5.86M | 3.04% | 7 |
|
|
2022
Q2 | – | Sell |
-3,821
| Closed | -$1.09M | – | 104 |
|
|
2022
Q1 | $1.09M | Buy |
3,821
+2,323
| +155% | +$665K | 0.56% | 47 |
|
|
2021
Q4 | $414K | Buy |
+1,498
| New | +$414K | 0.17% | 80 |
|
|
2020
Q3 | – | Sell |
-2,090
| Closed | -$343K | – | 107 |
|
|
2020
Q2 | $343K | Sell |
2,090
-2,132
| -50% | -$350K | 0.19% | 70 |
|
|
2020
Q1 | $586K | Buy |
+4,222
| New | +$586K | 0.44% | 44 |
|